Edwards Operating Cycle from 2010 to 2026

EW Stock  USD 85.13  0.55  0.65%   
Edwards Lifesciences Operating Cycle yearly trend continues to be fairly stable with very little volatility. Operating Cycle will likely drop to 191.98 in 2026. During the period from 2010 to 2026, Edwards Lifesciences Operating Cycle regression line of quarterly data had mean square error of  2,863 and geometric mean of  273.98. View All Fundamentals
 
Operating Cycle  
First Reported
2010-12-31
Previous Quarter
363.37
Current Value
191.98
Quarterly Volatility
60.80591944
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Edwards Lifesciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Edwards Lifesciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 89.9 M, Interest Expense of 15.7 M or Selling General Administrative of 2.2 B, as well as many indicators such as Price To Sales Ratio of 4.49, Dividend Yield of 0.0 or PTB Ratio of 4.78. Edwards financial statements analysis is a perfect complement when working with Edwards Lifesciences Valuation or Volatility modules.
  
Build AI portfolio with Edwards Stock
Check out the analysis of Edwards Lifesciences Correlation against competitors.

Latest Edwards Lifesciences' Operating Cycle Growth Pattern

Below is the plot of the Operating Cycle of Edwards Lifesciences Corp over the last few years. It is Edwards Lifesciences' Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Edwards Lifesciences' overall financial position and show how it may be relating to other accounts over time.
Operating Cycle10 Years Trend
Slightly volatile
   Operating Cycle   
       Timeline  

Edwards Operating Cycle Regression Statistics

Arithmetic Mean279.98
Geometric Mean273.98
Coefficient Of Variation21.72
Mean Deviation46.66
Median269.15
Standard Deviation60.81
Sample Variance3,697
Range212
R-Value0.52
Mean Square Error2,863
R-Squared0.27
Significance0.03
Slope6.31
Total Sum of Squares59,158

Edwards Operating Cycle History

2026 191.98
2025 363.37
2024 403.75
2023 378.25
2022 321.19
2021 262.75
2020 316.62

About Edwards Lifesciences Financial Statements

Edwards Lifesciences investors use historical fundamental indicators, such as Edwards Lifesciences' Operating Cycle, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Edwards Lifesciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Operating Cycle 363.37  191.98 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Edwards Stock Analysis

When running Edwards Lifesciences' price analysis, check to measure Edwards Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edwards Lifesciences is operating at the current time. Most of Edwards Lifesciences' value examination focuses on studying past and present price action to predict the probability of Edwards Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edwards Lifesciences' price. Additionally, you may evaluate how the addition of Edwards Lifesciences to your portfolios can decrease your overall portfolio volatility.